Clinical Trial Update: Single-dose Pharmacokinetics and Relative Bioavailability of an Oral Suspension and Two Tablet Formulations of BIA 2-093 [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating single-dose pharmacokinetics and relative bioavailability of an oral suspension and two tablet formulations of BIA 2-093 in epilepsy. R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• BIA 2-093

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2015-01-01